Clinical Trials Directory

Trials / Completed

CompletedNCT04859881

Risk Factors for Barotrauma in COVID-19

Risk Factors Associated With Barotrauma in COVID-19 Patients

Status
Completed
Phase
Study type
Observational
Enrollment
262 (actual)
Sponsor
Hospital General Ajusco Medio · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Barotrauma in mechanical ventilation (MV) is defined as lung damage attributable to the application of high airway pressure and is one of the potential mechanisms of ventilator-induced lung injury (VILI). Previous studies have shown an increased mortality in patients with barotrauma under MV; pneumothorax (PTX) being the most common presentation, but it can also present as pneumomediastinum (PM) with or without PTX, with extension to soft tissue as subcutaneous emphysema or even as pneumo-retroperitoneum and pneumo-scrotum. Traditionally, underlying lung disease or age are known risk factors for non-trauma related barotrauma. However, in patients with novel coronavirus disease (COVID-19), the incidence of this complication is more common than in non-infected patients, as recently reported. Since little is known regarding which are the main risk factors for these events to develop, most pathophysiological mechanisms remain unexplained. The aim of this study was to determine the risk factors for developing barotrauma in patients under MV with COVID-19 associated Acute Respiratory Distress Syndrome (ARDS). Secondary objectives were to determine the incidence of barotrauma and its association with mortality.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2020-04-01
Primary completion
2021-01-31
Completion
2021-01-31
First posted
2021-04-26
Last updated
2021-04-26

Locations

1 site across 1 country: Mexico

Source: ClinicalTrials.gov record NCT04859881. Inclusion in this directory is not an endorsement.